Intelligent Bio Solutions
INBS
1 hedge funds and large institutions have $8.45K invested in Intelligent Bio Solutions in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
0.13% less ownership
Funds ownership: 0.13% → 0% (-0.13%)
75% less funds holding
Funds holding: 4 → 1 (-3)
99% less capital invested
Capital invested by funds: $651K → $8.45K (-$642K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$346 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$367K |
| 2 |
Walleye Capital
New York
|
-$274K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $8.41K | +$346 | +1 | +4% |
|
2
Wells Fargo
San Francisco,
California
| $33 | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| – | -$367K | -1,055 | Closed |
|
|
4
Walleye Capital
New York
| – | -$274K | -801 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$1.78K | -5 | Closed |
|
INBS Hedge Fund Activity: Q2 2023 in Review
1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2023, worth a combined $8.45K — down 99% from $651K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of INBS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $346. The largest seller was Sabby Management, exiting entirely with an estimated $367K sold.
- 1 institutional investor held Intelligent Bio Solutions (INBS) as of Q2 2023, down from 4 in Q1 2023.
- Funds reported $8.45K of Intelligent Bio Solutions stock for Q2 2023, down 99% quarter-over-quarter.
- 0 funds opened new Intelligent Bio Solutions positions in Q2 2023 and 3 closed out, a net change of -3 holders.
- The largest Intelligent Bio Solutions buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $346 added.
- The largest Intelligent Bio Solutions seller in Q2 2023 was Sabby Management, an estimated $367K sold.
Based on aggregated 13F filings for Q2 2023.